Grifols SA
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- pharmaceutical industry [1]
- Company / filing name
- Grifols SA [2]
- Headquarters location
- Sant Cugat del Vallès [1]
- Founded
- 1909 [1]
- Legal form
- joint-stock company [1]
- Leadership in background record
- Víctor Grífols Deu; Raimon Grífols i Roura; Thomas Glanzmann; Nacho Abia [1]
- Official website
- https://www.grifols.com/en/home; https://www.grifols.com/de/home; https://www.grifols.com/es/home; https://www.grifolsplasma.com/ [1]
- Employees
- 23,234 · reported year 2021 [1]
- Annual revenue
- EUR 7,212,000,000 · reported year 2024 [1]
- ISIN (reported securities)
- ES0171996012 [1]
- CIK
- 1438569 [2]
- Country in background record
- Spain [1]
- Symbols / exchanges
- GRFS (Nasdaq), GIFLF (OTC), GIFOF (OTC), GIKLY (OTC) [2]
Company positioning and business
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. [3]
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. [3]
Background text: Wikipedia contributors, Grifols. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Management and corporate governance
The Wikidata background record identifies Víctor Grífols Deu; Raimon Grífols i Roura; Thomas Glanzmann; Nacho Abia in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [1]
Understanding company scale
Employees: 23,234 · reported year 2021. [1]
Annual revenue: EUR 7,212,000,000 · reported year 2024. [1]
Financial year, securities and disclosures
Listed securities: GRFS (Nasdaq), GIFLF (OTC), GIFOF (OTC), GIKLY (OTC). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Founding / inception date recorded in Wikidata. [1]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was Grifols SA founded?
Founded: 1909. The linked source provides the background record. [1]
Where is the headquarters of Grifols SA?
Headquarters location: Sant Cugat del Vallès. The linked source provides the background record. [1]
Which business sectors are recorded for Grifols SA?
Business sectors: pharmaceutical industry. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Grifols (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.